BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 15885610)

  • 1. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
    Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
    N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
    Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
    Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERC mutations in children with refractory cytopenia.
    Ortmann CA; Niemeyer CM; Wawer A; Ebell W; Baumann I; Kratz CP
    Haematologica; 2006 May; 91(5):707-8. PubMed ID: 16670076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
    Field JJ; Mason PJ; An P; Kasai Y; McLellan M; Jaeger S; Barnes YJ; King AA; Bessler M; Wilson DB
    J Pediatr Hematol Oncol; 2006 Jul; 28(7):450-3. PubMed ID: 16825992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.
    Liang J; Yagasaki H; Kamachi Y; Hama A; Matsumoto K; Kato K; Kudo K; Kojima S
    Haematologica; 2006 May; 91(5):656-8. PubMed ID: 16627250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J; Dokal I
    Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase gene mutation screening in Chinese patients with aplastic anemia.
    Han B; Liu B; Cui W; Wang X; Lin J; Zhao Y
    Leuk Res; 2010 Feb; 34(2):258-60. PubMed ID: 19942288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyskeratosis congenita.
    Vulliamy T; Dokal I
    Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
    Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS
    Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow failure and the new telomere diseases: practice and research.
    Young NS
    Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOLA1 gene mutations in acquired aplastic anemia.
    Pigullo S; Pavesi E; Dianzani I; Santamaria G; Svahn J; Risso M; Van Lint MT; Pillon M; Iori AP; Longoni D; Ramenghi U; Lanciotti M; Dufour C
    Pediatr Blood Cancer; 2009 Mar; 52(3):376-8. PubMed ID: 18989882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Savage SA; Stewart BJ; Weksler BB; Baerlocher GM; Lansdorp PM; Chanock SJ; Alter BP
    Blood Cells Mol Dis; 2006; 37(2):134-6. PubMed ID: 16934504
    [No Abstract]   [Full Text] [Related]  

  • 19. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
    Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
    Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.